Christopher H. Lieu

10.5k total citations · 3 hit papers
173 papers, 5.2k citations indexed

About

Christopher H. Lieu is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher H. Lieu has authored 173 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Oncology, 51 papers in Pathology and Forensic Medicine and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher H. Lieu's work include Colorectal Cancer Treatments and Studies (76 papers), Genetic factors in colorectal cancer (47 papers) and Cancer Genomics and Diagnostics (31 papers). Christopher H. Lieu is often cited by papers focused on Colorectal Cancer Treatments and Studies (76 papers), Genetic factors in colorectal cancer (47 papers) and Cancer Genomics and Diagnostics (31 papers). Christopher H. Lieu collaborates with scholars based in United States, Canada and Spain. Christopher H. Lieu's co-authors include Scott Kopetz, Michael J. Overman, John V. Heymach, Hai T. Tran, Swati Patel, C. Richard Boland, Jordan J. Karlitz, Timothy Yen, Cathy Eng and Dipen M. Maru and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Christopher H. Lieu

162 papers receiving 5.1k citations

Hit Papers

Impact of BRAF mutation and microsatellite instability on... 2011 2026 2016 2021 2011 2022 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
    2011 586 citations Christopher H. Lieu et al. profile →
  2. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection
    2022 412 citations Christopher H. Lieu et al. profile →
  3. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update
    2021 155 citations Nancy N. Baxter, Erin B. Kennedy et al. Journal of Clinical Oncology profile →

Peers

Christopher H. Lieu
Hiroyuki Uetake Japan
Mario Scartozzi Italy
Xiaoyun Liao United States
P Sismondi Italy
Frank T. Kolligs Germany
Langdon L. Miller United States
Jianping Xiong China
Mar Iglesias Spain
Seung Tae Kim South Korea
Jurriaan B. Tuynman Netherlands
Hiroyuki Uetake Japan
Christopher H. Lieu
Citations per year, relative to Christopher H. Lieu Christopher H. Lieu (= 1×) peers Hiroyuki Uetake

Countries citing papers authored by Christopher H. Lieu

Since Specialization
Citations

This map shows the geographic impact of Christopher H. Lieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Lieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Lieu more than expected).

Fields of papers citing papers by Christopher H. Lieu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher H. Lieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Lieu. The network helps show where Christopher H. Lieu may publish in the future.

Co-authorship network of co-authors of Christopher H. Lieu

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher H. Lieu. A scholar is included among the top collaborators of Christopher H. Lieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher H. Lieu. Christopher H. Lieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciombor, Kristen K., Lianchun Xiao, Enrica Marmonti, et al.. (2026). NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. Journal of Clinical Oncology. 44(6). 497–507.
2.
Pavlick, Dean C., S. Lindsey Davis, Christopher H. Lieu, et al.. (2025). Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study. ESMO Open. 10(6). 105312–105312.
3.
Franco, Salvador Rodriguez, Ying Jin, Oskar Franklin, et al.. (2024). Pathological Features Associated with Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors. Cancers. 16(16). 2922–2922.
4.
Lentz, Robert W., Patrick J. Blatchford, Kimberly R. Jordan, et al.. (2024). A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer. Clinical Cancer Research. 30(17). 3768–3778. 4 indexed citations
5.
Kim, Richard D., Mustapha Tehfé, Petr Kavan, et al.. (2024). Pembrolizumab Plus mFOLFOX7 or FOLFIRI for Microsatellite Stable/Mismatch Repair-Proficient Metastatic Colorectal Cancer: KEYNOTE-651 Cohorts B and D. Clinical Colorectal Cancer. 23(2). 118–127.e6. 8 indexed citations
6.
Davis, S. Lindsey, Wells A. Messersmith, W. Thomas Purcell, et al.. (2024). A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors. Cancers. 16(8). 1456–1456.
7.
Chen, Eric X., Petr Kavan, Mustapha Tehfé, et al.. (2024). Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E. Clinical Colorectal Cancer. 23(2). 183–193. 2 indexed citations
8.
Lieu, Christopher H., et al.. (2024). 633P First-in-human dose-escalation study of basroparib (STP1002) in patients with advanced-stage solid tumors. Annals of Oncology. 35. S504–S504.
9.
Lewis, Mark A., et al.. (2023). Biomarker Testing Trends in Patients With Metastatic Colorectal Cancer Who Live in Rural Areas and Urban Clusters in the US. The Oncologist. 28(11). e1118–e1122. 1 indexed citations
10.
11.
Amo‐Aparicio, Jesús, Shaikh M. Atif, Alberto Dinarello, et al.. (2023). Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment. Cancer Research Communications. 3(9). 1899–1911. 8 indexed citations
12.
Stuart, Christina M., Michael J. Kirsch, Cheryl Meguid, et al.. (2023). Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer. Surgery. 174(3). 654–659. 7 indexed citations
13.
Baxter, Nancy N., Erin B. Kennedy, Emily K. Bergsland, et al.. (2021). Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 40(8). 892–910. 155 indexed citations breakdown →
14.
Lieu, Christopher H., Erica A. Golemis, Ilya G. Serebriiskii, et al.. (2019). Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer. Clinical Cancer Research. 25(19). 5852–5858. 135 indexed citations
15.
Serebriiskii, Ilya G., Caitlin Connelly, Garrett M. Frampton, et al.. (2019). Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients. Nature Communications. 10(1). 3722–3722. 149 indexed citations
16.
17.
Chapman, Brandon C., Patrick Hosokawa, William G. Henderson, et al.. (2017). Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer. Journal of Surgical Oncology. 115(8). 1033–1044. 9 indexed citations
18.
Tai, David, Keith Wells, John J. Arcaroli, et al.. (2015). Targeting the WNT Signaling Pathway in Cancer Therapeutics. The Oncologist. 20(10). 1189–1198. 118 indexed citations
19.
Lieu, Christopher H., Lindsay A. Renfro, Aimery de Gramont, et al.. (2013). The impact of young age on survival in patients with metastatic colorectal cancer: Analysis from the ARCAD Clinical Trials Program. European Journal of Cancer. 49. 3 indexed citations
20.
Lieu, Christopher H., Laura Lambert, Robert A. Wolff, et al.. (2011). Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Annals of Oncology. 23(3). 652–658. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Uetake Breakdown of academic impact, for papers by Mario Scartozzi Breakdown of academic impact, for papers by Xiaoyun Liao Breakdown of academic impact, for papers by P Sismondi Breakdown of academic impact, for papers by Frank T. Kolligs Breakdown of academic impact, for papers by Langdon L. Miller Breakdown of academic impact, for papers by Jianping Xiong Breakdown of academic impact, for papers by Mar Iglesias Breakdown of academic impact, for papers by Seung Tae Kim Breakdown of academic impact, for papers by Jurriaan B. Tuynman
Rankless by CCL
2026